Innovation starts from the heart. At Edwards, we put patients first. We invest a significant proportion of our revenue towards research and development to drive and develop groundbreaking medical innovations for structural heart disease. As part of our R&D Engineering team, you will work closely with our Quality and Manufacturing teams to develop the latest tools and technologies to address significant, unmet clinical needs that impact patients’ lives around the world. Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient’s unmet clinical needs. It’s our driving force to help patients live longer and healthier lives. Join us and be part of our inspiring journey. How you will make an impact : This is a rare opportunity to join a fast-paced, passionate Delivery System R&D team, within Edwards Lifesciences’ Transcatheter Mitral and Tricuspid Therapies group, working on transcatheter replacement therapies to address Tricuspid disease. This team is deeply dedicated to transforming treatment to significantly improve patient lives around the world through valve replacement and we need your talent! This Engineer II role will support the next-generation system qualification and commercialization for a product line that offers a novel, highly efficacious therapy to a broad group of patients in need. With your help, this next-generation team will enable the continued growth of an innovative platform that supports a growing transcatheter tricuspid replacement therapy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
5,001-10,000 employees